Quality of life and scar evolution after negative pressure or conventional therapy for wound dehiscence following post‐bariatric abdominoplasty

Abstract

No studies have examined scars and quality of life after different treatments of wound dehiscence in patients undergoing post-bariatric abdominoplasty. Scars and quality of life of patients with postoperative wound dehiscence managed with negative pressure wound therapy (group A) and conventional wound therapy (group B) were reviewed 6 months after wound healing. Of 38 patients undergoing treatment for wound dehiscence after 203 abdominoplasty, 35 (group A = 14 versus group B = 21) entered the study. Wound healing in group A was significantly faster than group B (P = 0·001). Patients (P = 0·0001) and observers (P = 0·0001) reported better overall opinions on a scar assessment scale for group A. Better overall quality of life and general health satisfaction were observed in group A (P < 0·05). A significant correlation was observed between the World Health Organization Quality of Life scores and Patient and Observer Scar Assessment Scale scores (r=-0·68, P < 0·0001) in all 35 patients. Negative pressure wound therapy is feasible and effective in patients with wound dehiscence following post-bariatric abdominoplasty. An adequate post-treatment outcome is achieved compared with conventional wound therapy in light of a strong association found between worse patient scar self-assessment and poor overall quality of life, regardless of the received treatment.

Evaluation of inguinal vascular surgical scars treated with closed incisional negative pressure wound therapy using three‐dimensional digital imaging—A randomized controlled trial on bilateral incisions

“…20,21 The use of only the patient subscale, PSAS, of the POSAS is valid 21 and has been practiced in several previous studies. 35,36 There was a significant correlation between the objective and subjective scoring in the standard dressing group, which was not seen in the incisional NPWT group. This correlation was however not replicated at the second rating or for any of assessor number 2's ratings.…”

“…The applied scale, PSAS, was chosen for its high feasibility, intra‐rater and inter‐rater reliabilities . The use of only the patient subscale, PSAS, of the POSAS is valid and has been practiced in several previous studies …”

The Impact of Acne, Atopic Dermatitis, Skin Toxicities and Scars on Quality of Life and the Importance of a Holistic Treatment Approach

“… 41 Visible scars have the greatest impact on QoL while it appears that it is the presence of the scar rather than the severity which affects QoL. 42 One study revealed that patients wished scars in both visible and nonvisible sites were less noticeable and 91% would value even a small improvement in scarring. 43 Keloid and hypertrophic scars and chronic skin conditions have a similar impact on QoL due to internalized stigmatization, physical symptoms, and restricted mobility.…”

“…It has been shown that providing effective treatment for skin conditions improves QoL. 15 , 35 , 42 , 58 , 68–72 During chemotherapy and radiotherapy treatments, detecting and treating any skin toxicities early is essential. 73 Alongside treatments, focusing on techniques that patients already know including clothing choices, cleaning and emollients can help improve QoL.…”

Clinical Evaluation of Scar Quality Following the Use of Prophylactic Negative Pressure Wound Therapy in Obese Women Undergoing Cesarean Delivery

“…14 The PSAS subscale has previously been used without the observer subscale. 9,18 The EQ-5D-5L Questionnaire (EQ-5D) comprises 5 dimensions of health status: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each parameter has 5 levels, ranging from 1 (no problems) to 5 (extreme problems).…”